|
Quattrochi, L C; Yockey, C B; Barwick, J L et al. (1998) Characterization of DNA-binding proteins required for glucocorticoid induction of CYP3A23. Arch Biochem Biophys 349:251-60
|
|
Fontana, R J; deVries, T M; Woolf, T F et al. (1998) Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease. Br J Clin Pharmacol 46:221-8
|
|
Guzelian, P S (1997) Relevance of rat liver tumors to human hepatic and endometrial cancer. Semin Oncol 24:S1-105-S1-21
|
|
Zhang, Z Y; Kerr, J; Wexler, R S et al. (1997) Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation. Thromb Res 88:389-98
|
|
Kaminsky, L S; Zhang, Z Y (1997) Human P450 metabolism of warfarin. Pharmacol Ther 73:67-74
|
|
Brown, S E; Quattrochi, L C; Guzelian, P S (1997) Characterization of a pretranscriptional pathway for induction by phenobarbital of cytochrome P450 3A23 in primary cultures of adult rat hepatocytes. Arch Biochem Biophys 342:134-42
|
|
Sullivan-Klose, T H; Ghanayem, B I; Bell, D A et al. (1996) The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics 6:341-9
|
|
Barwick, J L; Quattrochi, L C; Mills, A S et al. (1996) Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10-6
|
|
Haehner, B D; Gorski, J C; Vandenbranden, M et al. (1996) Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 50:52-9
|
|
Fontana, R J; Turgeon, D K; Woolf, T F et al. (1996) The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity. Hepatology 23:1429-35
|
Showing the most recent 10 out of 39 publications
